TÌNH HÌNH BỆNH THẬN MẠN VÀ KẾT QUẢ BƯỚC ĐẦU ĐIỀU TRỊ Ở BỆNH NHÂN TĂNG HUYẾT ÁP TẠI THÀNH PHỐ CẦN THƠ: NGHIÊN CỨU THỰC HIỆN TRONG CỘNG ĐỒNG

Abstract

Background: Hypertension is a major risk factor for chronic kidney disease (CKD), while CKD also increases treatment costs, reduces quality of life, and causes hypertension. However, in Can Tho, there have not been many studies on the prevalence of CKD and the effectiveness of interventions in hypertensive patients. Objectives: To describe the prevalence of chronic kidney disease and to evaluate the preliminary outcomes of stage 3 CKD treatment in hypertensive patients in Can Tho City. Materials and methods: A cross-sectional descriptive and interventional study without control group was conducted on all hypertensive residents living in Can Tho City from January 2023 to September 2023. Results: The prevalence of CKD among patients is 18.2%. Among hypertensive patients with CKD, stage 1 CKD accounts for the highest proportion at 39.6%. Stages 3a and 3b CKD are 16% and 7.1%, respectively. More than half of stage 3 CKD patients achieved target blood pressure after intervention, and there were significant improvements in GFR and average systolic blood pressure after intervention (p<0.05). The majority of patients showed effective intervention outcomes in CKD progression (78.1%). Achieving target blood pressure and having stage 1 hypertension before intervention were associated with effective intervention outcomes (p<0.05). Conclusion: The prevalence of CKD among hypertensive patients was 18.2%. Achieving target levels of blood pressure and having stage 1 hypertension is related to the effectiveness of interventions in the progression of CKD.